HCA Healthcare, Inc. $HCA Shares Bought by OLD National Bancorp IN

Key Points

• OLD National Bancorp IN has increased its holdings in HCA Healthcare, Inc. by 70.7% during the second quarter, owning 1,791 shares worth approximately $686,000.
• Several hedge funds have recently acquired stakes in HCA, contributing to institutional investors owning 62.73% of the stock.
• HCA Healthcare's stock recently received a series of price target adjustments from analysts, with an average target price of $407.75 and ratings ranging from "Buy" to "Hold".

OLD National Bancorp IN increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 70.7% in the second quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 1,791 shares of the company's stock after purchasing an additional 742 shares during the period. OLD National Bancorp IN's holdings in HCA Healthcare were worth $686,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of HCA. Ameriflex Group Inc. purchased a new stake in shares of HCA Healthcare during the second quarter valued at approximately $27,000. Cheviot Value Management LLC purchased a new stake in HCA Healthcare during the 1st quarter worth $26,000. Saudi Central Bank acquired a new stake in shares of HCA Healthcare during the first quarter valued at about $26,000. WPG Advisers LLC acquired a new position in shares of HCA Healthcare in the first quarter worth about $27,000. Finally, Atwood & Palmer Inc. acquired a new stake in HCA Healthcare during the 1st quarter valued at approximately $28,000. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of research firms have recently weighed in on HCA. JPMorgan Chase & Co. raised their price target on shares of HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research report on Monday, August 4th. Morgan Stanley cut their target price on shares of HCA Healthcare from $410.00 to $400.00 and set an "equal weight" rating on the stock in a research note on Monday, July 28th. Royal Bank Of Canada lowered their price objective on HCA Healthcare from $404.00 to $401.00 and set an "outperform" rating for the company in a report on Monday, July 28th. Truist Financial boosted their price target on HCA Healthcare from $390.00 to $415.00 and gave the company a "buy" rating in a report on Wednesday, July 16th. Finally, Weiss Ratings reaffirmed a "buy (b-)" rating on shares of HCA Healthcare in a report on Saturday, September 27th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Moderate Buy" and an average target price of $407.75.

Insider Activity at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of HCA Healthcare stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president directly owned 31,503 shares in the company, valued at $13,194,716.52. The trade was a 10.85% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Company insiders own 1.30% of the company's stock.

HCA Healthcare Price Performance

Shares of HCA opened at $433.83 on Tuesday. HCA Healthcare, Inc. has a 12 month low of $289.98 and a 12 month high of $435.03. The company has a market cap of $101.51 billion, a P/E ratio of 18.24, a PEG ratio of 1.35 and a beta of 1.40. The stock has a fifty day moving average price of $399.40 and a 200 day moving average price of $373.65.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping analysts' consensus estimates of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The business had revenue of $18.61 billion for the quarter, compared to analysts' expectations of $18.49 billion. During the same quarter last year, the company earned $5.50 EPS. The company's revenue for the quarter was up 6.4% compared to the same quarter last year. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Tuesday, September 30th. Shareholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date of this dividend was Tuesday, September 16th. This represents a $2.88 annualized dividend and a yield of 0.7%. HCA Healthcare's payout ratio is presently 12.11%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.